Free Trial
NASDAQ:MVIS

MicroVision (MVIS) Stock Price, News & Analysis

$1.13
+0.03 (+2.64%)
(As of 09:32 AM ET)
Today's Range
$1.09
$1.13
50-Day Range
$0.89
$1.67
52-Week Range
$0.86
$4.71
Volume
80,145 shs
Average Volume
2.40 million shs
Market Capitalization
$233.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00

MicroVision MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
172.7% Upside
$3.00 Price Target
Short Interest
Bearish
25.94% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.20mentions of MicroVision in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.30 out of 5 stars

Computer And Technology Sector

550th out of 568 stocks

Electronic Components, Not Elsewhere Classified Industry

6th out of 6 stocks

MVIS stock logo

About MicroVision Stock (NASDAQ:MVIS)

MicroVision, Inc. develops and sells lidar sensors and software used in automotive safety and autonomous driving applications. It offers a suite of light detection and ranging (lidar) sensors and perception; and validation software for automotive OEMs, advanced driver-assistance systems, and autonomous vehicle applications, as well as non-automotive applications including industrial, robotics, and smart infrastructure. The company also provides MAVIN DR, a dynamic view lidar system, which combines short, medium, and long range sense and field of view into one form; lidar sensors under the MOVIA brand name; and MOSAIK, a software that automates manual data classification or annotation process. In addition, it provides engineering services for its hardware and software products. The company markets its products to customers directly, through trade shows, and its website. MicroVision, Inc. was founded in 1993 and is headquartered in Redmond, Washington.

MVIS Stock Price History

MVIS Stock News Headlines

LIDAR Quarterly Insights Q1 2024 Summary
I spent 44 years on Wall Street. If you knew what I know, you’d be terrified too.
The Most Important Presentation in America Right Now "Most people won't know what to do when their savings run out... Or when the stocks in their portfolios fall by half," says Wall Street icon Louis Navellier. "It's going to affect everything about our normal way of life: Our money, the value of our homes, our ability to retire." When it makes landfall, it's impact will be more violent and more severe than any financial crisis we've ever seen…
I spent 44 years on Wall Street. If you knew what I know, you’d be terrified too.
The Most Important Presentation in America Right Now "Most people won't know what to do when their savings run out... Or when the stocks in their portfolios fall by half," says Wall Street icon Louis Navellier. "It's going to affect everything about our normal way of life: Our money, the value of our homes, our ability to retire." When it makes landfall, it's impact will be more violent and more severe than any financial crisis we've ever seen…
MicroVision, Inc. (MVIS)
MVIS Apr 2024 4.000 call
MVIS Nov 2024 1.000 put
MVIS Apr 2024 2.000 call
MVIS Apr 2024 1.000 put
MicroVision launches $150 million equity offering
See More Headlines
Receive MVIS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MicroVision and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/09/2024
Today
7/08/2024
Next Earnings (Estimated)
8/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Electronic components, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:MVIS
Employees
340
Year Founded
1993

Price Target and Rating

Average Stock Price Target
$3.00
High Stock Price Target
$3.00
Low Stock Price Target
$3.00
Potential Upside/Downside
+172.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-82,840,000.00
Net Margins
-1,212.54%
Pretax Margin
-1,196.41%

Debt

Sales & Book Value

Annual Sales
$7.26 million
Book Value
$0.50 per share

Miscellaneous

Free Float
204,593,000
Market Cap
$227.33 million
Optionable
Optionable
Beta
3.04

Social Links

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

MVIS Stock Analysis - Frequently Asked Questions

How have MVIS shares performed this year?

MicroVision's stock was trading at $2.66 at the beginning of the year. Since then, MVIS stock has decreased by 58.6% and is now trading at $1.10.
View the best growth stocks for 2024 here
.

How were MicroVision's earnings last quarter?

MicroVision, Inc. (NASDAQ:MVIS) announced its quarterly earnings results on Thursday, May, 9th. The electronics maker reported ($0.13) EPS for the quarter. The electronics maker had revenue of $0.96 million for the quarter. MicroVision had a negative net margin of 1,212.54% and a negative trailing twelve-month return on equity of 90.04%.

What is Perry Mulligan's approval rating as MicroVision's CEO?

4 employees have rated MicroVision Chief Executive Officer Perry Mulligan on Glassdoor.com. Perry Mulligan has an approval rating of 74% among the company's employees.

How do I buy shares of MicroVision?

Shares of MVIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of MicroVision own?

Based on aggregate information from My MarketBeat watchlists, some other companies that MicroVision investors own include Organigram (OGI), Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Bionano Genomics (BNGO), Novan (NOVN), Aeterna Zentaris (AEZS) and Sorrento Therapeutics (SRNE).

This page (NASDAQ:MVIS) was last updated on 7/8/2024 by MarketBeat.com Staff

From Our Partners